Clinical Trial Update: Preventing Recurrent Ulcer Bleeding in Arthritis Patients Using Esomeprazole Plus Celecoxib [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating whether esomeprazole plus celecoxib can prevent recurrent ulcer bleeding in arthritis patients; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis
• Peptic Ulcer Disease

Drugs mentioned

• Celecoxib (Celecoxib)
• Esomeprazole (Esomeprazole)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Arthritis, Bleeding Ulcer | Phase 3 | Status: COMPLETED